Literature DB >> 35838195

Improvement in self-efficacy among older adults aging-in-place during COVID-19.

Lee A Lindquist1, Amber P Miller-Winder1, Allison Schierer1, Alaine Murawski1, Lauren Opsasnick1, Kwang-Youn Kim2, Vanessa Ramirez-Zohfeld1.   

Abstract

Entities:  

Year:  2022        PMID: 35838195      PMCID: PMC9349408          DOI: 10.1111/jgs.17946

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   7.538


× No keyword cloud information.

INTRODUCTION

Self‐efficacy is defined as an individual's belief in their capacity to execute behaviors necessary to produce specific performance attainments. It reflects confidence in the ability to exert control over one's own motivation, behavior, and environment. , Aging‐in‐place is a priority for many older adults and is defined as the ability to live in one's own home safely, independently, and comfortably. , , , During the COVID‐19 pandemic, restrictions forced many older adults into having to rely on their own skills to age‐in‐place. , With this research we sought to assess how older adult self‐efficacy was affected by the COVID‐19 pandemic.

METHODS

As part of a larger study, we are longitudinally following a cohort of older adults, who are aging‐in‐place, as they make decisions about accessing long‐term‐care services. , Subjects are surveyed at baseline and then every 6 months, thereafter for 42 months. COVID‐19 presented a unique challenge as baseline surveys began prior to the initial cases (January 2020) and continued during the initial 6 months of COVID‐19 (ending November 2020). In these baseline surveys, self‐efficacy was assessed using the validated PROMIS (Patient‐Reported Outcomes Measurement Information System): (1) General Self‐Efficacy which asks subjects to rate their level of confidence (e.g., I am not at all confident, I am a little confident, I am somewhat confident, I am quite confident, I am very confident) in managing situations (e.g., I am confident that I could deal efficiently with unexpected events; If I am in trouble, I can think of a solution, I can handle whatever comes my way). (2) Self‐Efficacy for Managing Chronic Conditions—Managing Social Interactions which asks subjects to rate their level of confidence (as above) for situations (e.g., I can talk about my health problems with someone; If I need help, I can find someone to take me to the doctor's office; I can get emotional support when I need it; I can ask for help when I do not understand something). We compared differences in self‐efficacy among subjects in relation to the COVID‐19 pandemic using T‐tests to evaluate differences.

RESULTS

A total of 214 subjects (n = 66 pre‐COVID‐19 pandemic and n = 148 during the COVID‐19 pandemic) completed the surveys (Table 1). PROMIS Self Efficacy for Managing Chronic Conditions—Managing Social Interactions was higher during the COVID pandemic (pre‐COVID 45.0 (6.1) vs. post‐COVID 48.7 (8.3), p = 0.02). Participants who completed their baseline during the COVID pandemic had significantly higher Self‐Efficacy for Managing Social Interactions t‐scores (β: 3.02; 95% CI: [0.15, 5.88]). PROMIS General Self Efficacy also trended higher among those assessed during the COVID‐19 pandemic (pre‐COVID 45.8 (7.7) vs. during COVID 43.7 (8.0), p = 0.07).
TABLE 1

Sociodemographic characteristics pre‐COVID versus during COVID (N = 214)

VariableTotal (N = 214)Pre‐COVID (n = 66)During COVID (n = 148) p‐value
Age, M (SD)71.04 (5.03)71.3 (4.96)70.91 (5.07)0.57
Sex, %
Male28.531.8227.030.47
Female71.568.1872.97
Race %
Black31.1346.1524.490.007
White58.0244.6263.95
Other10.859.2311.56
Education, %
HS or less15.0927.699.520.009
Some college20.7516.9222.45
College graduate18.415.3819.73
Graduate degree45.7540.048.3
Income, %
<$10,0005.428.064.26<0.001
$10,000–$24,99915.7627.4210.64
$25,000–49,99926.635.4822.7
≥$50,00052.2229.0362.41
Employment status, %
Working for pay25.8227.6925.00.68
Retired/unemployed74.1872.3175.0
Marital status, %
Married45.7540.048.300.26
Unmarried/widowed54.2560.051.70
Total # comorbidities, M (SD)2.33 (1.46)2.62 (1.58)2.2 (1.39)0.049
Power of attorney, %
Yes60.2846.9766.220.018
No38.325033.11
Relationship to POA, %
Spouse25.724.2426.35N/A
Child25.2319.7027.70
Other family member10.287.5811.49
Friend5.616.065.41
Attorney/lawyer0.931.520.68
Other3.276.062.03
Living will, %
Yes57.4848.4861.490.11
No41.1248.4837.84
Advanced directive, %
Yes51.8746.9754.050.544
No43.465040.54
Sociodemographic characteristics pre‐COVID versus during COVID (N = 214)

DISCUSSION

During the COVID‐19 pandemic, older adults aging‐in‐place in their homes exhibited increased levels of self‐efficacy. Our results show that older adults experienced increased confidence in managing their social interactions in the home (Figure 1).
FIGURE 1

Change in self‐efficacy during COVID‐19

Change in self‐efficacy during COVID‐19 COVID‐19 restrictions forced older adults to fend for themselves and live in isolation or risk facing a deadly virus. Prior to COVID‐19, many older adults may have assumed they would be able to live independently but may have had reservations or self‐doubt about being completely cut‐off from loved ones. In experiencing the COVID‐19 restrictions, older adults may have overcome any self‐doubt, experiencing what being homebound entails and managing effectively. If they were able to endure COVID‐19 isolation, older adults likely felt that they could manage anything—including future homebound scenarios. As self‐efficacy is defined as an individual's belief in their capacity to effectively execute behaviors, older adults during COVID‐19 exhibited a stronger belief that they could manage aging‐in‐place effectively. Limitations existed in that it was difficult to distinguish if the COVID‐19 isolation was the direct cause of the change in self‐efficacy or if there were other socio‐environmental factors that led to this difference. Another limitation is that this is a cross‐sectional sample and lacks additional longitudinal follow‐up time points. Will self‐efficacy continue to change as time progresses? Will older adults experience less or return to a lower level of self‐efficacy as we move further down the road of COVID‐19? Since we are following this cohort every 6 months, we will be able to observe how self‐efficacy changes during future phases of the COVID‐19 pandemic. Self‐doubt is a part of human nature. COVID‐19 restrictions forced older adults to experience the loss of in‐person human interactions and overcome their self‐doubt in managing social interactions. Older adults adapted to the challenges of isolated aging‐in‐place and came ahead with higher self‐efficacy. Future studies will help determine if the higher self‐efficacy gained during the COVID‐19 pandemic remains or extends the ability of older adults to age‐in‐place.

AUTHOR CONTRIBUTIONS

All authors met criteria for authorship by (1) Conception and design of the study: Lindquist, Ramirez‐Zohfeld. (2) Data acquisition: Miller, Scherier, Murawski, Ramirez‐Zohfeld. (3) Analysis and interpretation of data: Lindquist, Miller, Scherier, Curtis, Opsasnick, Kim, Ramirez‐Zohfeld. (4) Manuscript drafting: Lindquist, Miller, Scherier, Opsasnick, Kim, Ramirez‐Zohfeld. (5) Revising the manuscript critically for important intellectual content: All authors. (6) Approval of the version of the manuscript to be published: All authors.

CONFLICT OF INTEREST

All authors declare no conflict of interest.

SPONSOR'S ROLE

The sponsor was not involved in the design, methods, analysis and interpretation of the data, and preparation of the manuscript.
  8 in total

1.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

2.  Home: the place the older adult cannot imagine living without.

Authors:  Catharina Gillsjö; Donna Schwartz-Barcott; Iréne von Post
Journal:  BMC Geriatr       Date:  2011-03-17       Impact factor: 3.921

3.  PlanYourLifeSpan.org - an intervention to help seniors make choices for their fourth quarter of life: Results from the randomized clinical trial.

Authors:  Lee A Lindquist; Vanessa Ramirez-Zohfeld; Priya D Sunkara; Chris Forcucci; Dianne S Campbell; Phyllis Mitzen; Jody D Ciolino; Dyanna Gregory; Gayle Kricke; Kenzie A Cameron
Journal:  Patient Educ Couns       Date:  2017-06-27

Review 4.  The psychosocial adaptability of independently living older adults to COVID-19 related social isolation in the Netherlands: A qualitative study.

Authors:  Evi M Kremers; Jeroen H M Janssen; Minke S Nieuwboer; Marcel G M Olde Rikkert; G M E E Geeske Peeters
Journal:  Health Soc Care Community       Date:  2021-05-24

5.  Predictors of preferred location of care in middle-aged individuals of a municipality in Japan: a cross-sectional survey.

Authors:  Kentaro Sugimoto; Masayo Kashiwagi; Nanako Tamiya
Journal:  BMC Health Serv Res       Date:  2017-05-15       Impact factor: 2.655

6.  Rationale and study design for decision making & implementation of aging-in-place/long term care plans among older adults.

Authors:  Lee A Lindquist; Ruqayyah Muhammad; Amber P Miller-Winder; Lauren Opsasnick; Kwang-Youn Kim; Julia Yoshino Benavente; Michael Wolf; Vanessa Ramirez-Zohfeld
Journal:  Contemp Clin Trials Commun       Date:  2021-03-16

7.  Improvement in self-efficacy among older adults aging-in-place during COVID-19.

Authors:  Lee A Lindquist; Amber P Miller-Winder; Allison Schierer; Alaine Murawski; Lauren Opsasnick; Kwang-Youn Kim; Vanessa Ramirez-Zohfeld
Journal:  J Am Geriatr Soc       Date:  2022-07-15       Impact factor: 7.538

8.  COVID-19 exposures and infection control among home care agencies.

Authors:  Theresa A Rowe; Mallika Patel; Rachel O'Conor; Sheila McMackin; Vicki Hoak; Lee A Lindquist
Journal:  Arch Gerontol Geriatr       Date:  2020-07-30       Impact factor: 3.250

  8 in total
  1 in total

1.  Improvement in self-efficacy among older adults aging-in-place during COVID-19.

Authors:  Lee A Lindquist; Amber P Miller-Winder; Allison Schierer; Alaine Murawski; Lauren Opsasnick; Kwang-Youn Kim; Vanessa Ramirez-Zohfeld
Journal:  J Am Geriatr Soc       Date:  2022-07-15       Impact factor: 7.538

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.